Insomnia

American Family Physician

Volumn 59, Issue 7, 1999, Pages 1911-1916

  Eddy, Mark ^a   Walbroehl, Gordon S ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CAFFEINE; CALCIUM BROMOLACTATE; DEXAMPHETAMINE; DIPHENHYDRAMINE; DOXYLAMINE; ESTAZOLAM; FENTHION; FLURAZEPAM; MELATONIN; METHYLPHENIDATE; NON PRESCRIPTION DRUG; OXAZEPAM; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; QUAZEPAM; QUINIDINE; QUINIDINE POLYGALACTURONATE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; SLEEP EZE; TEMAZEPAM; THEOPHYLLINE; TRIAZOLAM; UNCLASSIFIED DRUG; ZOLDIPEM; ZOLPIDEM TARTRATE;

BEHAVIOR THERAPY; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL FACTOR; INSOMNIA; INTERMETHOD COMPARISON; PSYCHOLOGICAL ASPECT; REVIEW;

BEHAVIOR THERAPY; CIRCADIAN RHYTHM; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATIENT EDUCATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; TEACHING MATERIALS;

EID: 0033119086     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998;21:178-86.
2. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF 3d, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997;278:2170-7.
3. Mendelson WB. Long-term follow-up of chronic insomnia. Sleep 1995;18:698-701.
4. Kales JD, Kales A, Bixler EO, Soldatos CR, Cadieux RJ, Kashurba GJ, et al. Biopsychobehavioral correlates of insomnia, V: clinical characteristics and behavioral correlates. Am J Psychiatry 1984;141:1371-6.
5. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-84.
6. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
7. Stoller MK. Economic effects of insomnia. Clin Ther 1994;16:873-97.
8. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994:553-7.
9. Lichstein KL, Riedel BW. Behavioral assessment and treatment of insomnia: a review with an emphasis on clinical application. Behavior Therapy 1994;25: 659-88.
10. Kupfer DJ, Reynolds CF 3d. Management of insomnia. N Engl J Med 1997;336:341-6.
11. Practice parameters for the use of polysomnography in the evaluation of insomnia. Standards of Practice Committee of the American Sleep Disorders Association. Sleep 1995;18:55-7.
12. Zhdanova IV, Lynch HJ, Wurtman RJ. Melatonin: a sleep-promoting hormone. Sleep 1997;20:899-907.
13. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 1997;20:908-15.
14. Mendelson WB. A critical evaluation of the hypnotic efficacy of melatonin. Sleep 1997;20:916-9.
15. Mendelson WB. Efficacy of melatonin as a hypnotic agent. J Biol Rhythms 1997;12:651-6.
16. Eisendrath SJ. Psychiatric disorders. In: Tierney LM Jr, McPhee SJ, Papadakis MA, eds. Current medical diagnosis and treatment. 38th ed. Stamford, Conn.: Appleton & Lange, 1999:1030.
17. Walsh JK, Engelhardt CL. Trends in the pharmacologic treatment of insomnia. J Clin Psychiatry 1992; 53:10-7.
18. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151: 1172-80.
19. Hauri PJ. Can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep 1997;20: 1111-8.
20. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995;63:79-89.